7-[18F]Fluoro-8-azaisatoic Anhydrides: Versatile Prosthetic Groups for the Preparation of PET Tracers

18F-Fluorination of sensitive molecules is often challenging, but can be accomplished under suitably mild conditions using radiofluorinated prosthetic groups (PGs). Herein, 1-alkylamino-7-[18F]fluoro-8-azaisatoic anhydrides ([18F]AFAs) are introduced as versatile 18F-labeled building blocks that can be used as amine-reactive or “click chemistry” PGs. [18F]AFAs were efficiently prepared within 15 min by “on cartridge” radiolabeling of readily accessible trimethylammonium precursors. Conjugation with a range of amines afforded the corresponding 2-alkylamino-6-[18F]fluoronicotinamides in radiochemical conversions (RCCs) of 15–98%. In addition, radiolabeling of alkyne- or azide-functionalized precursors with azidopropyl- or propargyl-substituted [18F]AFAs using Cu-catalyzed click cycloaddition afforded the corresponding conjugates in RCCs of 44–88%. The practical utility of the PGs was confirmed by the preparation of three 18F-labeled PSMA ligands in radiochemical yields of 28–42%. Biological evaluation in rats demonstrated excellent in vivo stability of all three conjugates. In addition, one conjugate ([18F]JK-PSMA-15) showed favorable imaging properties for high-contrast visualization of small PSMA-positive lesions.

[1]  B. Neumaier,et al.  Validation of analytical HPLC with post-column injection as a method for rapid and precise quantification of radiochemical yields. , 2023, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  M. Perkins,et al.  Reaction of [18F]Fluoride at Heteroatoms and Metals for Imaging of Peptides and Proteins by Positron Emission Tomography , 2021, Frontiers in Chemistry.

[3]  H. Endepols,et al.  Rapid 18F-labeling via Pd-catalyzed S-arylation in aqueous medium. , 2021, Chemical communications.

[4]  Allen F. Brooks,et al.  On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion. , 2020, Nuclear medicine and biology.

[5]  M. Lam,et al.  PSMA PET/CT in primary prostate cancer diagnostics: an overview of the literature , 2020, Tijdschrift voor Urologie.

[6]  H. G. van der Poel,et al.  Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study , 2020, BMC Cancer.

[7]  C. Kim,et al.  On-demand radiosynthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) on an electrowetting-on-dielectric microfluidic chip for 18F-labeling of protein , 2019, RSC advances.

[8]  A. Drzezga,et al.  Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer , 2019, EJNMMI Research.

[9]  F. Mottaghy,et al.  Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents , 2019, BMC Cancer.

[10]  A. Drzezga,et al.  Discovery of 18F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions , 2018, The Journal of Nuclear Medicine.

[11]  P. Choyke,et al.  Rapid synthesis of maleimide functionalized fluorine-18 labeled prosthetic group using "radio-fluorination on the Sep-Pak" method. , 2018, Journal of labelled compounds & radiopharmaceuticals.

[12]  R. Mach,et al.  Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight. , 2017, Nuclear medicine and biology.

[13]  Steven H. Liang,et al.  18 F-Labeling of Sensitive Biomolecules for Positron Emission Tomography. , 2017, Chemistry.

[14]  A. Windhorst,et al.  Fluorine-18 labelled building blocks for PET tracer synthesis. , 2017, Chemical Society reviews.

[15]  K. Rittinger,et al.  Determination of the pKa of the N-terminal amino group of ubiquitin by NMR , 2017, Scientific Reports.

[16]  P. Choyke,et al.  Facile room temperature synthesis of fluorine-18 labeled fluoronicotinic acid-2,3,5,6-tetrafluorophenyl ester without azeotropic drying of fluorine-18. , 2016, Nuclear medicine and biology.

[17]  B. Hadaschik,et al.  F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  B. Neumaier,et al.  Seyferth-Gilbert homologation as a route to 18F-labeled building blocks: Preparation of radiofluor-inated phenylacetylenes and their application in PET chemistry , 2016 .

[19]  Xiaoyuan Chen,et al.  Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes , 2014, Bioconjugate chemistry.

[20]  B. Neumaier,et al.  Neither azeotropic drying, nor base nor other additives: a minimalist approach to (18)F-labeling. , 2014, Organic & biomolecular chemistry.

[21]  T. Holland-Letz,et al.  Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  U. Haberkorn,et al.  [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  M. Pomper,et al.  2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer , 2011, Clinical Cancer Research.

[24]  F. Mottaghy,et al.  New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors. , 2011, Chemistry.

[25]  A. Scott,et al.  A simplified protocol for the automated production of succinimidyl 4‐[18F]fluorobenzoate on an IBA Synthera module , 2011 .

[26]  S. Reske,et al.  Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep). , 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[27]  M. Finn,et al.  Tailored ligand acceleration of the Cu-catalyzed azide-alkyne cycloaddition reaction: practical and mechanistic implications. , 2010, Journal of the American Chemical Society.

[28]  C.伯恩哈特,et al.  Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs , 2010 .

[29]  A. Cuthbertson,et al.  One step radiosynthesis of 6-[(18)F]fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester ([(18)F]F-Py-TFP): a new prosthetic group for efficient labeling of biomolecules with fluorine-18. , 2010, Journal of medicinal chemistry.

[30]  S. Luthra,et al.  Two-step radiosynthesis of [18F]N-succinimidyl-4-fluorobenzoate ([18F]SFB) , 2009 .

[31]  A. Kozikowski,et al.  A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer. , 2009, Journal of medicinal chemistry.

[32]  Pius August Schubiger,et al.  Molecular imaging with PET. , 2008, Chemical reviews.

[33]  M. Zalutsky,et al.  Synthesis of N-succinimidyl 4-[18F]fluorobenzoate, an agent for labeling proteins and peptides with 18F , 2006, Nature Protocols.

[34]  W. Heston,et al.  Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer , 2004, Journal of cellular biochemistry.

[35]  R. Leahy,et al.  High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. , 1998, Physics in medicine and biology.

[36]  M. Zalutsky,et al.  Fluorine-18-labeled [Nle4,d-Phe7]-α-MSH, an α-melanocyte stimulating hormone analogue , 1997 .

[37]  M. Zalutsky,et al.  Fluorine-18 labeled chemotactic peptides: a potential approach for the PET imaging of bacterial infection. , 1995, Nuclear medicine and biology.

[38]  M. Vaultier,et al.  Aliphatic amino azides as key building blocks for efficient polyamine syntheses , 1993 .

[39]  D. Bigner,et al.  Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  M. Hursthouse,et al.  Polyfluorinated heterocyclic compounds. Part 29[1]. The synthesis of 4,5,6,7,8-pentafluoro-2H-cyclohepta[b]furan-2-one and its reaction with sodium methoxide. , 1991 .

[41]  W. Jencks,et al.  Concerted bimolecular substitution reactions of acetal derivatives of propionaldehyde and benzaldehyde , 1989 .

[42]  G. L. Watkins,et al.  Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: Improved synthesis of [18F]GBR‐13119 , 1989 .

[43]  L. Shchegoleva,et al.  Polyfluorinated heterocyclic compounds , 1970 .

[44]  H. Hall,et al.  Correlation of the Base Strengths of Amines1 , 1957 .

[45]  US 20090082426A,et al.  PREPARATION THEREOF AND THERAPEUTIC USE THEREOF , 2017 .

[46]  E. Dubinsky,et al.  Reaction to , 2007 .